|
Nephrology and Hypertension Journal Club Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease February 21 2025 |
02/21/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Small Glucarpidase for Treatment of High-Dose Methotrexate Toxicity February 28 2025 |
02/28/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury March 14 2025 |
03/14/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Circulating Angiogenic Factor Levels in Hypertensive Disorders of Pregnancy March 21 2025 |
03/21/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Cell free DNA for the detection of kidney allograft rejection March 28 2025 |
03/28/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Effect of Continuing Versus Withholding SGLT2 Inhibitors on Incidence of Contrast Associated AKI in Patients Undergoing Coronary Angiography April 18 2025 |
04/18/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Oral Semaglutide and Cardiovascular Outcomes in High Risk Type 2 Diabetes April 25 2025 |
04/25/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Stopping Versus Continuing Metformin in Patients with Advanced CKD A Nationwide Scottish Target Trial Emulation Study May 2 2025 |
05/02/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Presentation and outcome in carries of pathogenic variants in SLC34A1 and SLC34A3 encoding sodium phosphate transporter NPT 2a and 2c May May 9 2025 |
05/09/2025 - 7:30am to 8:30am |
|
Nephrology and Hypertension Journal Club Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis May 16 2025 |
05/16/2025 - 7:30am to 8:30am |
Facebook
X
LinkedIn
Forward